Advertisement

Topics

Companies Related to "Phase studies with filgotinib small bowel fistulizing Crohn" [Most Relevant Company Matches] - Page: 20 RSS

09:36 EDT 21st March 2019 | BioPortfolio

Here are the most relevant search results for "Phase studies with filgotinib small bowel fistulizing Crohn" found in our extensive corporate database of over 50,000 company records.

Showing "Phase studies with filgotinib small bowel fistulizing Crohn" Companies 476–500 of 3,400+

Probably Relevant

CEL-SCI Corporation

CEL-SCI Corporation is developing products that empower immune defenses. Its lead product is Multikine. In Phase II clinical trials Multikine was shown to be safe and well-tolerated, and to improve the patients' overall survival by 33 percent at a median of three and a half years following surgery. A pivotal Phase III clinical trial with Multikine in head ...


Expression Genetics, Inc

An Alabama-based specialty biopharmaceutical company developing safe and efficient polymeric delivery systems to be used to create products for treatment of human diseases. Our delivery vehicles, based on a synthetic biocompatible polymeric system can be used to deliver therapeutic genes and small molecules. The delivery systems function by protecting the therapeutic cargo from degradation, promot...

NuCana

NuCana® is a rapidly growing, clinical stage biopharmaceutical company with a broad development portfolio of novel anti-cancer medicines. The Company’s proprietary ProTide technology has the potential to set new benchmarks in efficacy and safety with its treatments that are specifically designed to overcome key cancer resistance mechanisms. Acelari...


Colonix Medical Limited

Colonix Medical Limited has pioneered and refined a new system for the early detection / screening of colorectal cancer and other bowel diseases such as IBD. This system can be used for both symptomatic and non symptomatic patients. Colorectal cancer is often referred to as ‘the silent killer’. If detected early, colorectal cancer treatments are effective and after treatment most sufferers ca...

INCAM

INCAM has institute structure, two experimental stations located in the field. From its direct interaction with the medium, the benefit for producers, technicians, professionals and companies will arise. The services of the consultant cabinets of INCAM include practically all problems the production sector has to face. INCAM S.A. provides with complete services to the pharmaceutical, veterinary, a...

Dance Pharma

Dance is a San Francisco based, global company focused exclusively on creating a line of small, patient friendly, pain-less, low cost insulin inhalers for the world diabetes market. In addition to providing inhaled insulin to those who have become insulin dependent, the company also intends to enable introduction of insulin much earlier in the disease proc...

Chiasma (Israel), LTD

Chiasma develops new drug products based on its proprietary Transient Permeability Enhancer (TPE) technology, which enables oral delivery of macromolecules (up-to 20 kDa) and poorly-absorbed small molecules into the GI wall, portal system and then to the systemic circulation. Chiasma creates its internal pipeline by selecting approved macromolecules that are currently available in injectable form...

immatics biotechnologies GmbH

"immatics is a biopharmaceutical company from Tuebingen/Germany. With presently 40 employees immatics develops peptide-based therapeutic vaccines for oncology. The most advanced product candidate, IMA901, addresses the unmet medical need in renal cell carcinoma. Based on very encouraging results from a recently completed phase 1 trial, IMA901 will soon be transferred to phase 2 clinical testing. A...

Aastrom Biosciences, Inc.

Founded in 1989 and with headquarters in Ann Arbor, Michigan, Aastrom Biosciences is dedicated to the development of stem cell treatments for critical cardiovascular diseases. Aastrom is currently evaluating its autologous cellular therapies in US clinical trials in the treatment of dilated cardiomyopathy (DCM). These critical diseases are associated with significant morbidity and mortality and ...

Gentiae

The Company was created in 2000 as the for-profit extension of the world-renowned Ischemia Research and Education Foundation (IREF), a non-profit research organization with 18 years of experience in cardiovascular clinical studies. Gentiae draws on this exclusive knowledge base in cardiovascular medicine and employs a full-time staff of exceptionally talented scientific and medical professionals w...

Fluorous Technologies Inc.

Fluorous technology offers a novel approach to solution phase chemistry and delivers significant benefits when applied to high-throughput synthesis and purification. The use of light fluorous compounds (permanent or temporarily tagged) in conjunction with fluorous sorbents yields the following benefits: Broad applicability to solution phase chemistry with no special reaction conditions or solvents...

Afferent Pharmaceuticals

Afferent Pharmaceuticals is focused on developing first-in-class medicines to treat chronic pain by targeting P2X3 receptors in nerve fibers. Research shows that P2X3-containing receptors are highly specific to nerve fibers that transmit the sensations of pain and discomfort in response to inflammation or injury, particularly in chronic conditions. P2X3...

The West Clinic

In 1979, Dr. William West opened a small two-room, three physician cancer clinic in downtown Memphis that forever changed the face of cancer care for thousands of patients in the Mid-South and beyond. A native Memphian, Dr. West was among several physicians in his family; his father and two brothers were also doctors. His decision to enter the medical field was predicated on his interest in cancer...

Tetragenex Pharmaceuticals Inc

Originally founded as Innapharma in 1989, Tetragenex Pharmaceuticals Inc. is a privately held biopharmaceutical company working to discover, develop and commercialize proprietary pharmaceutical products that treat serious diseases for which current therapies are inadequate. Since 1990, we have synthesized and patented a novel platform of pharmaceutical “small chain” peptides that treat depress...

DOR BioPharma, Inc.

DOR BioPharma, Inc. (DOR) is a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. DOR's lead product, orBec(R) (oral beclomethasone dipropionate or BDP), is a potent, locally acting corticosteroid being developed for the treatment of GI GVHD, a comm...

PHARMBIODYN Consulting Group

25 Years Pharmbiodyn The privately owned company Dr. Gerhard Friedrich PHARMBIODYN has been a provider of services to the pharmaceutical and biotechnology industries since December1978. The company is based in Denzlingen, approximately 10 km from Freiburg (Germany). In January 2000 the development of a new equipment for full automation of LC-MS was finished and used in the analysis of sample...

Microbiotica

Microbiotica was established in 2016 to develop and commercialise ground-breaking research into the role of the human microbiome in health and disease and its application to medicine conducted in the Host-Microbiotica Interactions Laboratory (“HMIL”) at the Sanger Institute. The Company was founded by Dr Mike Romanos, Dr Trevor Lawley and Profess...

Ricerca Biosciences LLC

Ricerca Biosciences' integrated drug discovery service model is the only one in North America that can take hit compounds, then utilize medicinal chemistry coupled with ADMET to optimize those hits either at Ricerca or cost-effectively via our synthetic chemistry partnership, and take your compound deep into preclinical toxicology (in vivo), and then to an IND.Our process chemistry group and pilo...

Opexa Therapeutics

Opexa Therapeutics is a commercialization driven biotechnology cellular therapy company that develops autologous personalized cell therapies for the treatment of various diseases. The Company is focused on its proprietary stem cell and T-cell technologies for the autologous use of peripheral blood derived adult stem cells in regenerative medicine as well as T cells for the treatment of autoimmune ...

ClinSource NV

ClinSource is a clinical information technology company, supporting clinical research environments for the pharmaceutical, medical device and biotechnology industry.TrialXSTM, the integrated clinical research software environment, helps life science companies to bring innovative treatments to market faster. Treatments such as drugs, medical devices and combination products are studied in clinical ...

Cadent Therapeutics

Cadent Therapeutics is creating breakthrough therapies for the treatment of movement disorders and cognitive impairment. The company combines target specificity, patient selection, drug design and optimization, and novel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders. Cadent Therapeutics is rapidly advan...

Center for Immigration Studies

Argonaut Technologies

Argonaut Technologies provides innovative technology that enables chemists to use parallel chemistry to improve productivity and accelerate discovery and development. Our products include organic synthesizers, software and chemical resins and reagents for solution-phase and solid-phase chemistry. Argonaut has assembled a world-class team of experienced organic chemists, engineers and software prog...

IOmet Pharma

IOmet Pharma Ltd is a privately-held drug discovery company based in Edinburgh, UK. Founded in 2008, IOmet is focused on the development of innovative medicines for the treatment of cancer, with particular emphasis on the fields of cancer immunotherapy and cancer metabolism. IOmet has a team with a proven track record of success in bringing small molecules...

Taconic

Taconic was founded in 1952 as a family-owned business in New York's Hudson River Valley. Since then, the company has grown to become one of the largest laboratory rodent providers in the world with a reputation for quality, service and integrity. With five breeding facilities and three service laboratories in the USA and Europe, a staff of over 700, and a commitment to technological innovation, T...


More From BioPortfolio on "Phase studies with filgotinib small bowel fistulizing Crohn"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks